Skip to content

In this Innovation Insights, we highlight five advancements we found interesting this quarter. These breakthroughs are protecting our bodies from heart disease, our homes from grid blackouts, and our digital information from quantum hackers. We believe that innovation is everywhere. As new technologies and products intersect every facet of our lives, the economic impact of innovation will continue to be as profound as it is pervasive.

Deep-sea metal mining can power the energy transformation

Exhibit 1: Polymetallic nodules on the seabed contain valuable industrial metals

Image courtesy of NOAA Office of Ocean Exploration and Research

The seafloor is littered with riches critical for powering the modern world. Every million years, a few millimeters of metal deposited on the ocean floor builds up fist-sized “polymetallic nodules” containing manganese, nickel and cobalt—essential ingredients for batteries.1 By dredging the muddy floor, these nodules can be collected. Mining, whether by land or sea, raises environmental concerns; however, collecting deep-sea nodules could be 90% less carbon-intensive than land mining.2 The International Seabed Authority has issued permits; as regulatory hurdles are removed, we anticipate innovation in underwater robotics and autonomous subsea vehicles will lower the technological barriers to extracting these seafloor resources.

Why it matters: The energy transformation requires unprecedented amounts of metals to support battery manufacturing for energy storage and electric vehicles (EVs). Meeting the supply demands with ethical sourcing of key materials drives innovation to the depths of the ocean.

Weight-loss drugs deliver outsized results

New drugs treating obesity are moving forward in the market, with the latest experimental drug (retatrutide) helping patients lose an average of 24% body weight over 48 weeks.3 Weekly injections expose the brain to different hormone levels causing patients to lose the craving for food and consume fewer calories. The latest trials on one compound found a 20% decrease in the risk of heart disease and stroke in obese patients.4 These positive health effects open the door to more insurance coverage and increased adoption for these drugs.

Why it matters: About 42% of American adults are obese, which is associated with a wide range of serious medical complications including diabetes, liver disease and heart disease.3 We are seeing discoveries that address one health condition (obesity) showing knock-on effects for other conditions—in this case, the leading cause of death (heart disease.)

In a blackout, EVs shine through the darkness

EVs are providing essential home backup power during storms, rolling blackouts and peak demand days.5 Some EV battery packs are around 100 kWh–over 7x larger than a standard home AC battery system. One EV can power a home, consuming 29 kWh of daily electricity,6 for over 80 hours! Bidirectional charging for vehicle-to-home (V2H) today is limited, but eventually vehicle-to-grid (V2G) technology can enable “virtual power plants” of EV fleets to help meet demand during peak hours.7

Why it matters: As intermittent power sources add stress and complexity to the electric grid, EVs can act as a balancing force for stability—especially in emergency situations. As innovation in batteries and power electronics evolves hand in hand with EV adoption, versatile energy technologies will play a critical role in powering our lives.

New encryption protects against quantum computer hacking

Researchers released a new encryption algorithm that is resistant to quantum computer attacks.8 The FIDO2 “Fast Identity Online” industry standard authentication has become the most secure website login without relying on passwords. However, biometric identity data, such as Face ID and Touch ID, is stored in databases protected with traditional RSA encryption. While RSA encryption relies on math problems that are hard to solve, a quantum computer could crack the code in eight hours. The new hybrid approach, combining a battle-tested algorithm with a standardized quantum-resistant algorithm,9 can start securing public keys before an eventual quantum computer attack on private information.

Why it matters: From private banking data to personal medical information, our digital security boils down to encryption standards that protect against “classical” computers but are easily cracked by quantum computers. Innovation at the intersection of cryptography and quantum technology, byte and atom, is necessary to secure our digital future.

Wearable ultrasound device spots early breast cancer

Researchers at the Massachusetts Institute of Technology have developed a flexible patch that can be incorporated into a bra for ultrasound monitoring of high-risk breast cancer patients. The device uses a 3D-printed patch with a new piezoelectric material that miniaturizes the scanner. The portable device can provide real-time screening between biennial mammograms with a similar resolution to medical imaging centers. This additional data can better screen for “interval cancers,” tumors developed between mammograms, that account for nearly 30% of breast cancer cases.10

Why it matters: The survival rate of early diagnosis of breast cancer is nearly 100%, while later stage diagnosis falls to a 25% survival rate.10 Innovation in medical devices and form factors provides additional health care data to increase the quality of treatment, and survival rate, for the most common form of cancer.

There are also risks in investing in this or any asset class. The initial potential of any asset class may not carry over to any specific company or the entire asset class chosen for investment, over any investment time period. Any of the investment assumptions may never come to fruition. Investors should be prepared for potential losses as well as the possibility of investment gains. Ideas, products, companies or entire asset classes with positive past performance are not indicate of future results.

 



IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market.

Data from third party sources may have been used in the preparation of this material and Franklin Templeton Investments (“FTI”) has not independently verified, validated or audited such data. FTI accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FTI affiliates and/or their distributors as local laws and regulation permits. Please consult your own professional adviser or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Investments entail risks, the value of investments can go down as well as up and investors should be aware they might not get back the full value invested.

Issued in Luxembourg by Franklin Templeton International Services S.à r.l. Investors can also obtain these documents free of charge from any of the following local authorised FTI representatives: Switzerland: Issued by Franklin Templeton Switzerland Ltd, Talstrasse 41, CH-8001 Zurich.

Australia: Issued by Franklin Templeton Australia Limited (ABN 76 004 835 849, AFSL 240827), Level 47 120 Collins Street, Melbourne, Victoria, 3000. Austria/Germany: Issued by Franklin Templeton Investment Services GmbH, Mainzer Landstraße 16, D-60325 Frankfurt am Main, Germany. Authorised in Germany by IHK Frankfurt M., Reg. no. D-F-125-TMX1-08. Tel. 08 00/0 73 80 01 (Germany), 08 00/29 59 11 (Austria), Fax: +49(0)69/2 72 23-120, [email protected]Canada: Issued by Franklin Templeton Investments Corp., 5000 Yonge Street, Suite 900 Toronto, ON, M2N 0A7, Fax: (416) 364-1163, (800) 387-0830, www.franklintempleton.ca. Netherlands: Issued by Franklin Templeton International Services Sàrl, Dutch branch, NoMA House, Gustav Mahlerlaan 1212, 1081 LA, Amsterdam. United Arab Emirates: Issued by Franklin Templeton Investments (ME) Limited, authorized and regulated by the Dubai Financial Services Authority. Dubai office: Franklin Templeton Investments, The Gate, East Wing, Level 2, Dubai International Financial Centre, P.O. Box 506613, Dubai, U.A.E., Tel.: +9714-4284100 Fax:+9714-4284140. France: Issued by Franklin Templeton France S.A., 20 rue de la Paix, 75002 Paris France. Hong Kong: Issued by Franklin Templeton Investments (Asia) Limited, 17/F, Chater House, 8 Connaught Road Central, Hong Kong. Italy: Issued by Franklin Templeton International Services S.à.r.l. – Italian Branch, Corso Italia, 1 – Milan, 20122, Italy. Japan: Issued by Franklin Templeton Investments Japan Limited. Korea: Issued by Franklin Templeton Investment Trust Management Co., Ltd., 3rd fl., CCMM Building, 12 Youido-Dong, Youngdungpo-Gu, Seoul, Korea 150-968. Luxembourg/Benelux: Issued by Franklin Templeton International Services S.à r.l. – Supervised by the Commission de Surveillance du Secteur Financier - 8A, rue Albert Borschette, L-1246 Luxembourg - Tel: +352-46 66 67-1- Fax: +352-46 66 76. Malaysia: Issued by Franklin Templeton Asset Management (Malaysia) Sdn. Bhd. & Franklin Templeton GSC Asset Management Sdn. Bhd. Poland: Issued by Templeton Asset Management (Poland) TFI S.A.; Rondo ONZ 1; 00-124 Warsaw. Romania: Issued by Bucharest branch of Franklin Templeton Investment Management Limited (“FTIML”) registered with the Romania Financial Supervisory Authority under no. PJM01SFIM/400005/14.09.2009,, and authorized and regulated in the UK by the Financial Conduct Authority. Singapore: Issued by Templeton Asset Management Ltd. Registration No. (UEN) 199205211E. 7 Temasek Boulevard, #38-03 Suntec Tower One, 038987, Singapore. Spain: FTIS Branch Madrid, Professional of the Financial Sector under the Supervision of CNMV, José Ortega y Gasset 29, Madrid, Spain. Tel +34 91 426 3600, Fax +34 91 577 1857. South Africa: Issued by Franklin Templeton Investments SA (PTY) Ltd which is an authorised Financial Services Provider. Tel: +27 (21) 831 7400 ,Fax: +27 (21) 831 7422. Switzerland: Issued by Franklin Templeton Switzerland Ltd, Talstrasse 41, CH-8001 Zurich. UK: Issued by Franklin Templeton Investment Management Limited (FTIML), registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL Tel +44 (0)20 7073 8500. Authorized and regulated in the United Kingdom by the Financial Conduct Authority. Nordic regions: Issued by Franklin Templeton International Services S.à r.l. , Contact details: Franklin Templeton International Services S.à.r.l., Swedish branch c/o Cecil Coworking, Norrlandsgatan 10, 111 43 Stockholm, Sweden. Tel +46 (0)8 545 012 30, [email protected], authorised in the Luxembourg by the Commission de Surveillance du Secteur Financier to conduct certain financial activities in Denmark, in Sweden, in Norway, in Iceland and in Finland. Offshore Americas: In the U.S., this publication is made available only to financial intermediaries by Templeton/Franklin Investment Services, 100 Fountain Parkway, St. Petersburg, Florida 33716. Tel: (800) 239-3894 (USA Toll-Free), (877) 389-0076 (Canada Toll-Free), and Fax: (727) 299-8736. Investments are not FDIC insured; may lose value; and are not bank guaranteed. Distribution outside the U.S. may be made by Templeton Global Advisors Limited or other sub-distributors, intermediaries, dealers or professional investors that have been engaged by Templeton Global Advisors Limited to distribute shares of Franklin Templeton funds in certain jurisdictions. This is not an offer to sell or a solicitation of an offer to purchase securities in any jurisdiction where it would be illegal to do so.
Please visit www.franklinresources.com to be directed to your local Franklin Templeton website.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.